Project ID: 1UG3NS120172

Investigators: Daniel Friedman

Dataset Size: 0 B

Files: 0

Description:

To advance the development of next-generation personalized therapies for long-term seizure freedom, we urgently need technologies that improve seizure diagnostics while reducing risks associated with invasive neurosurgical procedures. Among the more than 1,000,000 Americans with uncontrolled focal epilepsy, many have poorly localized seizure foci. These individuals face the highest rates of ‘failure’ (i.e., ongoing seizures) after epilepsy surgery. To meet this need for safer, more effective invasive electrode studies and simultaneously enable discovery to advance next-generation therapies, this project leverages a successful, long-term collaboration between clinicians, engineers, material scientists, neuroscientists and industrial partners at New York University School of Medicine, University of Pennsylvania, Duke University, the University of Utah, Blackrock Neurotech, and Dyconex, AG to translate modern thin-film technology into next generation FDA-approved implantable neurological devices. We have developed and extensively tested a novel electrode array based on liquid crystal polymer thin-film (LCP-TF) technology. When combined with large-scale data acquisition systems, LCP-TF electrodes will provide higher quality neural recordings than existing FDA-approved electrode arrays, with improved safely and at an affordable cost.

For questions about this dataset, contact daniel.friedman@nyulangone.org

Files